Tokyo, Dec. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059761) titled 'prospective evaluation study of time to creation for ESCR after EUS-guided hepaticogastrostomy' on Dec. 1.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Osaka Medical and Pharmaceutical University
Condition:
Condition - Time to creation of ESCR
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Time to creation of ESCR
Basic objectives2 - Safety
Intervention:
Interventions/Control_1 - EUS-HGS stent removal between 7 days to 14days
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - 1. EUS-HGS using metal stent
2. Patients who will undergo trans-ESCR procedure
2. Age over 18, under 99yo
Key exclusion criteria - Patients who undergo stent removal
Target Size - 40
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 07 Month 26 Day
Date of IRB - 2025 Year 11 Month 13 Day
Anticipated trial start date - 2025 Year 12 Month 01 Day
Last follow-up date - 2030 Year 07 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068338
Disclaimer: Curated by HT Syndication.
